FORM 10-Q
                                           
                          SECURITIES AND EXCHANGE COMMISSION
                                           
                                WASHINGTON, D.C. 20549
                                           
(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934

                     For the quarterly period ended June 30, 1996
                                           
                                          OR
                                           
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934

                For the transition period from ________ to ___________
                                           
                           Commission file number: 1-11144
                                           

                            REGENCY HEALTH SERVICES, INC.
                                           
State or other jurisdiction of                             (I.R.S. Employer
incorporation or organization                              Identification No.)

    DELAWARE                                                  33-0210226


                            Regency Health Services, Inc.
                                   2742 Dow Avenue 
                              Tustin, California  92780
                                     714-544-4443


    Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes   X  No ____

    Indicate the number of shares outstanding of each of the registrant's
classes of common stock, as of the latest practicable date.

    Title                                                       Outstanding
    -----                                                       -----------
Common Stock                                                    16,173,695





                          PART I.     FINANCIAL INFORMATION
                                           
ITEM 1.  FINANCIAL STATEMENTS.


                            REGENCY HEALTH SERVICES, INC.
                             CONSOLIDATED BALANCE SHEETS
                           (In thousands, except par value)

                                        ASSETS




                                                                     JUNE 30,       DECEMBER 31,
                                                                      1996            1995
                                                                  -----------      ------------
                                                                   (Unaudited)
                                                                             
CURRENT ASSETS:
    Cash and cash equivalents                                     $  66,900         $ 104,238
    Restricted cash                                                   4,400                 -
    Accounts receivable, net of allowances of $4,150 at 
      June 30, 1996 and $3,757 at December 31, 1995                  79,737            54,050
    Notes and other receivables                                       1,369             2,182
    Deferred income taxes                                             5,447             5,447
    Assets held for sale                                              7,640             8,970
    Other current assets                                              8,046             6,396
                                                                  ---------         ---------

            Total current assets                                    173,539           181,283
                                                                  ---------         ---------

PROPERTY AND EQUIPMENT:
    Land                                                             21,281            21,249
    Buildings and improvements                                      101,432            96,396
    Leasehold interest - other                                       17,554            17,556
    Leasehold interest - related party                                2,075             2,075
    Equipment                                                        29,384            24,610
                                                                  ---------         ---------

                                                                    171,726           161,886
    Less - accumulated depreciation and amortization                (39,131)          (34,679)
                                                                  ---------         ---------

            Total property and equipment                            132,595           127,207
                                                                  ---------         ---------

OTHER ASSETS:
    Mortgage notes receivable, net of allowances of $949 at
      June 30, 1996 and $951 at December 31, 1995                     4,651             5,163
    Goodwill, net of accumulated amortization of $2,023 at
      June 30, 1996 and $563 at December 31, 1995                    57,951            13,621
    Other assets, net of accumulated amortization of $3,323 at
      June 30, 1996 and $2,206 at December 31, 1995                  31,201            15,697
                                                                  ---------         ---------

            Total other assets                                       93,803            34,481
                                                                  ---------         ---------

                                                                   $399,937         $ 342,971
                                                                  ---------         ---------
                                                                  ---------         ---------






The accompanying notes are an integral part of these consolidated financial
statements.




                            REGENCY HEALTH SERVICES, INC.
                        CONSOLIDATED BALANCE SHEETS (CONTINUED)
                           (In thousands, except par value)

                         LIABILITIES AND STOCKHOLDERS' EQUITY





                                                                     June 30,       December 31,
                                                                      1996            1995
                                                                  -----------      ------------
                                                                   (Unaudited)
                                                                             
CURRENT LIABILITIES:
    Current portion of long-term debt                             $  51,438            $4,371
    Accounts payable                                                 24,748            22,285
    Accrued expenses                                                  4,828             5,946
    Accrued compensation                                             21,023            18,051
    Accrued workers' compensation                                     4,892             5,377
    Deferred revenue                                                  1,428             1,743
    Accrued interest                                                  4,197             4,231
                                                                  ---------         ---------

          Total current liabilities                                 112,554            62,004


LONG-TERM DEBT, NET OF CURRENT PORTION                              183,607           179,615
OTHER LIABILITIES AND NONCURRENT RESERVES                            11,878            13,017
DEFERRED INCOME TAXES                                                10,414             7,946
                                                                  ---------         ---------

          Total liabilities                                         318,453           262,582
                                                                  ---------         ---------
OMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY:
    Common stock, $.01 par value; authorized - 35,000
      shares; 16,174 and 16,670 shares issued and outstanding
      at June 30, 1996 and December 31, 1995, respectively              167               167
    Additional paid-in capital                                       51,972            56,679
    Retained earnings                                                29,345            23,543
                                                                  ---------         ---------

          Total stockholders' equity                                 81,484            80,389
                                                                  ---------         ---------

                                                                  $ 399,937         $ 342,971
                                                                  ---------         ---------
                                                                  ---------         ---------





The accompanying notes are an integral part of these consolidated financial
statements.





                            REGENCY HEALTH SERVICES, INC. 
                        CONSOLIDATED STATEMENTS OF OPERATIONS 
                      (In thousands, except per share amounts) 




                                                                                   THREE MONTHS ENDED           SIX MONTHS ENDED 
                                                                                         JUNE 30,                    JUNE 30, 
                                                                                  ----------------------      ---------------------
                                                                                    1996         1995           1996         1995 
                                                                                    ----         ----           ----         ----

                                                                                       (Unaudited)                 (Unaudited) 
                                                                                                               
NET OPERATING REVENUE                                                            $137,632      $99,766        $267,595    $197,314
                                                                                ---------    ---------       ---------   ---------

COSTS AND EXPENSES: 
    Operating expenses                                                            112,567       80,881         218,693     159,853

    Corporate general and administrative                                            5,617        4,450          11,680       9,698

    Rent expense                                                                    6,178        4,205          11,690       8,358

    Depreciation and amortization                                                   3,836        2,336           7,186        4,622

    Interest expense                                                                4,194        1,925           8,346        3,835

    Class action suit settlement                                                        -        3,098               -        3,098
                                                                                ---------    ---------       ---------    ---------

       Total costs and expenses                                                   132,392       96,895         257,595     189,464
                                                                                ---------    ---------       ---------   ---------

INCOME BEFORE PROVISION FOR INCOME TAXES                                            5,240        2,871          10,000       7,850
PROVISION FOR INCOME TAXES                                                          2,175        1,091           4,198       2,983
                                                                                ---------    ---------       ---------   ---------

NET INCOME                                                                       $  3,065     $  1,780        $  5,802    $  4,867
                                                                                ---------    ---------       ---------   ---------
                                                                                ---------    ---------       ---------   ---------



INCOME PER COMMON SHARE: 

    Primary                                                                      $   0.19     $   0.11        $   0.35    $   0.29
                                                                                ---------    ---------       ---------   ---------
                                                                                ---------    ---------       ---------   ---------

    Fully diluted                                                                $   0.18     $   0.11        $   0.33    $   0.29
                                                                                ---------    ---------       ---------   ---------
                                                                                ---------    ---------       ---------   ---------


WEIGHTED AVERAGE SHARES OF COMMON STOCK 
    AND EQUIVALENTS: 
    Primary                                                                        16,382       16,600          16,617      16,594
                                                                                ---------    ---------       ---------   ---------
                                                                                ---------    ---------       ---------   ---------

    Fully diluted                                                                  20,341       20,567          20,573      20,548
                                                                                ---------    ---------       ---------   ---------
                                                                                ---------    ---------       ---------   ---------





The accompanying notes are an integral part of these consolidated financial
statements. 




                            REGENCY HEALTH SERVICES, INC.
                        CONSOLIDATED STATEMENTS OF CASH FLOWS
                                    (in thousands)
                                           





                                                                        SIX MONTHS ENDED
                                                                             JUNE 30,

                                                                      1996              1995
                                                                     -----             ----
                                                                           (Unaudited)
                                                                               

CASH FLOWS FROM OPERATING ACTIVITIES:
    Net income                                                     $  5,802          $  4,867
    Adjustments to reconcile net income to
     net cash provided by (used in) operating activities:
      Depreciation and amortization                                   7,186             4,622
      Deferred income taxes and charge in lieu of taxes               2,468             1,252
      Other, net                                                        296                 2
      Change in cash from changes in assets and liabilities,
          excluding effects of acquisitions and dispositions:
          Accounts receivable                                       (24,158)           (1,359)
          Other current assets                                          335               234
          Current and other liabilities                               2,033             3,418
                                                                  ---------         ---------

        Net cash provided by (used in) operating activities          (6,038)           13,036
                                                                  ---------         ---------

 CASH FLOWS FROM INVESTING ACTIVITIES:

    Proceeds from mortgage notes receivable                             109                87
    Acquisitions                                                    (48,183)               --
    Purchases of property and equipment                              (5,600)           (7,829)
    Changes in other assets, net                                     (5,823)            1,242
                                                                  ---------         ---------

        Net cash used in investing activities                       (59,497)           (6,500)
                                                                  ---------         ---------

CASH FLOWS FROM FINANCING ACTIVITIES:
    Payments on long-term debt                                       (4,898)           (2,727)
    Proceeds from exercise of warrants and options                      232                99
    Proceeds from exercise of stock appreciation rights                  --               615
    Purchase of treasury stock                                       (5,082)               --
    Workers' compensation trust funding                             (10,637)               --
    Proceeds from issuance of long-term debt                         48,582             1,066
                                                                  ---------         ---------

        Net cash provided by (used in) financing activities          28,197              (947)
                                                                  ---------         ---------

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                (37,338)            5,589

CASH AND CASH EQUIVALENTS, beginning of period                      104,238            25,677
                                                                  ---------         ---------

CASH AND CASH EQUIVALENTS, end of period                         $   66,900        $   31,266
                                                                  ---------         ---------
                                                                  ---------         ---------







SUPPLEMENTAL SCHEDULE OF NONCASH INVESTING AND FINANCING ACTIVITIES:

    During the six months ended June 30, 1995, $20,000 of the Company's
    Convertible Subordinated Debentures were converted into 1,616 shares of
    common stock.

                The accompanying notes are an integral part of these 
                          consolidated financial statements.





                            REGENCY HEALTH SERVICES, INC.
                      NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                     (UNAUDITED)
                                           


1.      BASIS OF PRESENTATION

        The unaudited consolidated financial statements and related notes have
been prepared pursuant to the rules and regulations of the Securities and
Exchange Commission. Accordingly, certain information and footnote disclosures
normally included in financial statements prepared in accordance with generally
accepted accounting principles have not been presented. The accompanying
unaudited financial statements and related notes should be read in conjunction
with the consolidated financial statements and related notes included in Regency
Health Services, Inc.'s ("Regency" or the "Company") 1995 Annual Report on Form
10-K.

        In the opinion of the management of Regency, all material adjustments
necessary to present fairly the Company's financial condition, results of
operations, and changes in financial position have been made. All material
intercompany balances, profits, and transactions have been eliminated. The
consolidated results of operations presented are not necessarily indicative of
the consolidated results for a full year.

        The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period.  Actual results could differ from those estimates.

        Certain amounts in the 1995 financial statements have been reclassified
to conform to the 1996 presentation.

2.      ACQUISITIONS

        Effective January 2, 1996, the Company completed the acquisition of the
assets of Assist-A-Care, a pharmacy located in San Diego, California.  The
purchase price was $5.8 million, comprised of $3.2 million cash and a
$2.6 million note payable.

        Effective February 1, 1996, the Company acquired leasehold interests in
18 health care facilities in Tennessee and North Carolina with 2,375 beds from
Liberty Healthcare Limited Partnership ("Liberty") through an asset purchase for
$39.3 million cash and a note payable for $2.2 million.   The Company also
acquired Executive Pharmacy with a $763,000 note payable and an enteral feeding
business for $1.5 million cash from businesses affiliated with Liberty.  In
addition, the Company paid $400,000 cash for the inventory of Liberty.  A
portion of the purchase was funded with notes payable, which may be reduced as a
result of certain seller liabilities and audit adjustments.  Escrow accounts
established at the time of purchase were funded with $2.96 million for payment
on the notes payable and are included in other assets on the accompanying
consolidated balance sheet as of June 30, 1996.

        On April 1, 1996, the Company completed the acquisition of the assets
of Buena Vista Nursing Center ("Buena Vista"), a health care facility with 64
skilled nursing beds and 22 assisted living beds, located in Lexington, North
Carolina.  The purchase price was $2.875 million, consisting of $2.675 million
in cash and a $200,000 note payable.  Payment of the note is dependent upon
Buena Vista attaining certain financial performance targets.

        These transactions were accounted for using the purchase method of
accounting under generally accepted accounting principles.  Revenues and
expenses are included in the accompanying financial statements subsequent to the
purchase date.  The purchase price allocation related to these transactions has
not yet been finalized.




        The following unaudited pro forma condensed consolidated statements of
earnings present the summarized consolidated results of operations of the
Company after giving effect to the acquisitions of Liberty and Liberty-
affiliated businesses for the six months ended June 30, 1996 and 1995, as if
such acquisitions had been consummated on January 1, 1995 (in thousands, except
per share data):


                                                            SIX MONTHS ENDED
                                                                 JUNE 30,
                                                      -------------------------
                                                          1996          1995
                                                      -----------   -----------
                                                               (Unaudited)

        Net operating revenue                          $ 274,401     $ 237,113
        Total costs and expenses                         263,820       228,813
                                                      ----------    ----------
        Income before provision for income taxes          10,581         8,300
        Provision for income taxes                         4,442         3,163
                                                      ----------    ----------

        Net income                                     $  6,139      $   5,137
                                                      ----------    ----------
                                                      ----------    ----------

        Income per common share -                                             

             Primary                                   $   0.37      $    0.31
                                                      ----------    ----------
                                                      ----------    ----------

             Fully diluted                             $   0.35      $    0.30
                                                      ----------    ----------
                                                      ----------    ----------


        The pro forma results are presented for informational purposes only and
are not necessarily indicative of what results of operations actually would have
been had such acquisitions been consummated at the beginning of such period or
of future operations or results.  The effect of the other acquisitions is
immaterial.

3.      DISPOSITIONS

        On March 1, 1996, the Company disposed of a 98-bed facility in Lynwood,
California resulting in a $182,000 charge against the reserve established in the
fourth quarter 1995.

4.      WORKERS' COMPENSATION CLAIMS TRUST

        In 1995, the Company established a revocable workers' compensation
claims trust ("Trust") to pre-fund its workers' compensation obligations.  The
Trust was funded in March 1996 with approximately $10.6 million from available
cash.  Of the remaining $9.2 million in the Trust at June 30, 1996, $4.4 million
was classified as current restricted cash and $4.8 million was classified as
other long-term assets.

5.      ISSUANCE OF SUBORDINATED NOTES

        On June 28, 1996, the Company issued 12 1/4% Subordinated Notes (the
"Subordinated Notes") in an aggregate amount of $50 million.  Interest on the 
Notes will be payable semi-annually on January 15 and July 15 of each year, 
commencing January 15, 1997.  The Subordinated Notes will mature on July 15, 
2003, unless previously redeemed.  Net proceeds received by the Company 
totaled approximately $48.4 million and funded the redemption of the 
Company's outstanding 6 1/2% Convertible Subordinated Debentures due 2003 
(the "Convertible Subordinated Debentures") on July 29, 1996 (see  Note 7 - 
Subsequent Event). The Subordinated Notes contain certain covenants similar 
to the 9-7/8% Senior Subordinated Notes, including limitations on the ability 
of the 





Company to, among other things, (a) incur additional indebtedness and issue
redeemable preferred stock, (b) sell equity interests in subsidiaries, (c) make
certain restricted payments (as defined), (d) create liens, and (e) engage in
mergers, consolidations or transfers of substantially all of the assets of the
Company to another party. 

6.      NET INCOME PER SHARE

        For the three and six months ended June 30, 1996 and 1995, primary
income per share was calculated based on the weighted average number of common
and common equivalent shares outstanding during the periods.  For the three and
six months ended June 30, 1996 and 1995, fully diluted income per share was
computed as described above and includes the issuance of common shares upon the
assumed conversion of the Convertible Subordinated Debentures.  Additionally,
interest and amortization of underwriting costs related to such debentures were
added, net of tax, to income for the purpose of calculating fully diluted income
per share.  Such amounts aggregated $496,000 and $509,000 for the three months
ended June 30, 1996 and 1995, respectively, and $984,000 and $1,019,000 for the
six months ended June 30, 1996 and 1995, respectively.

7.      SUBSEQUENT EVENT

        On July 29, 1996, the Company completed the redemption of all $48.9
million of its outstanding Convertible Subordinated Debentures for cash at such
amount.  The redemption was financed through the issuance of the Subordinated
Notes and available cash. The redemption reduces fully diluted shares by 3.9
million shares.  The full amount of outstanding Convertible Subordinated
Debentures is recorded in the current portion of long-term debt at June 30,
1996.



        

ITEM 2: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

GENERAL

        The following table sets forth certain operating data for the Company
on the dates indicated:


                                                                 JUNE 30,
                                                          ---------------------
                                                            1996         1995
                                                           ------       ------
        In-patient operations
            Facilities. . . . . . . . . . . . . . . . .      112            93
            Licensed beds . . . . . . . . . . . . . . .   11,541         9,134
            Subacute beds . . . . . . . . . . . . . . .    1,108         1,028
            Subacute units. . . . . . . . . . . . . . .       46            43

        Contract rehabilitation therapy operations(1)
             Non-affiliated facilities served . . . . .       86            --
             Regency operated facilities served . . . .       49            --
                                                           ------         -----
                      Total . . . . . . . . . . . . . .      135            --
                                                           ------         -----
                                                           ------         -----

        Pharmacy operations
            Non-affiliated facilities served  . . . . .       76             5
            Regency operated facilities served. . . . .       60            34
                                                           ------         -----
                      Total . . . . . . . . . . . . . .      136            39
                                                           ------         -----
                                                           ------         -----

__________________

(1)   The Company did not provide contract rehabilitation therapy services
      until the acquisition of SCRS & Communicology, Inc. ("SCRS") in July 1995.


IN-PATIENT OPERATIONS

        The Company's in-patient operations derive its net operating revenue
from the performance of routine and ancillary services at the Company's
facilities.  Revenue from routine services is comprised of charges for room and
board and basic nursing services for the care of patients, including those in
the Company's subacute specialty units. Revenue from ancillary services is
comprised of charges for rehabilitative services, subacute specialty services,
and pharmaceutical products and services provided to patients at the Company's
facilities. In-patient operations derive most of its ancillary services revenue
from Medicare- and HMO-eligible patients.  The Company has classified revenue
from in-patient operations as either basic nursing care revenue or subacute
revenue.  Basic nursing care revenue includes charges for room and board for
non-Medicare and non-HMO patients.  Subacute revenue includes room and board and
basic nursing services for Medicare and HMO patients and revenues from all
ancillary services provided to patients at the Company's facilities.

        The Company's growth strategy includes the selective acquisition of
both new facilities as well as other service providers.  The Company incurs
certain costs and experiences operating inefficiencies in connection with the
acquisition of a new facility following such acquisition, relating to the
integration of such facility's financial and administrative systems, physical
plant and other aspects of its operations into those of the Company.  In
addition, the introduction of a substantial portion of the Company's contract
rehabilitation therapy, pharmacy and other ancillary services to a new facility
may take as long as 12 months to fully implement.  There can be no assurance
that each of the service providers the Company may acquire will be profitable,
or that the acquisition of new facilities that result in significant integration
costs and inefficiencies will not adversely affect the Company's profitability. 




        During the fourth quarter of 1995 the Company exchanged leasehold
interests in three healthcare facilities with 360 beds in New Mexico for
leasehold interests in four healthcare facilities with 461 beds in Ohio
previously operated by another company.  In October 1995, the Company also
opened a newly constructed facility and disposed of one additional facility.

        In December 31, 1995, the Company determined to dispose of 13
facilities located in California as part of its strategic plan of diversifying
from the California Medicaid system ("Medi-Cal").  The results of operations of
these facilities will continue to be reflected in the Company's financial
statements until the disposition is completed. In March 1996, the Company
disposed of one of the thirteen facilities with 98 beds.

        Effective February 1, 1996, the Company acquired 18 healthcare
facilities with 2,375 beds in Tennessee and North Carolina (see Note 2 to the
Consolidated Financial Statements).

        In addition, effective April 1, 1996, the Company acquired 1 healthcare
facility in North Carolina with 86 beds.

ANCILLARY BUSINESSES OPERATIONS

        In July 1995, the Company acquired SCRS which provides rehabilitation
services to Company-operated and non-affiliated healthcare facilities in 14
states in the West, Midwest, and Southeast.  In the second quarter 1996, 65% of
SCRS revenues were derived from providing services to non-affiliated healthcare
providers. 

        The Company's pharmacy operations provide prescription services and
basic pharmaceutical dispensing programs to Company and third party healthcare
facilities.  During the first six months of 1996 and 1995, 65% and 55%,
respectively, of revenues from pharmacy operations were derived from providing
services to non-affiliated healthcare providers and patients at Regency
facilities billed directly to third-party payors.  In January and February of
1996, the Company acquired three additional pharmacy operations (see Note 2 to
the Consolidated Financial Statements).

        The Company's 29 home healthcare locations provide skilled nursing,
rehabilitation and other services in selected areas in California and Ohio. 


        The acquisitions occurring in the first and second quarters 1996 are
collectively referred to as the "1996 Acquisitions." 




RESULTS OF OPERATIONS

    The following table sets forth the amounts of certain elements of net
operating revenue and the percentage of total net operating revenue for the
periods presented:




                                                                                              THREE MONTHS ENDED JUNE 30,
                                                                                              ---------------------------    
                                                                                            1996                        1995     
                                                                                            ----                        ----
                                                                                                 (dollars in thousands)
                                                                                                                   
Basic nursing care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    $70,660           51%        $58,443          59%
Subacute . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     42,915           32          31,425          31
                                                                                ---------        -----       ---------        ----
    Total in-patient operations. . . . . . . . . . . . . . . . . . . . . . . .    113,575           83          89,868          90
Home healthcare operations . . . . . . . . . . . . . . . . . . . . . . . . . .      8,856            6           7,529           7
Contract rehabilitation therapy operations to
     non-affiliates (1). . . . . . . . . . . . . . . . . . . . . . . . . . . .      9,292            7              --          --
Pharmacy operations to non-affiliates (2). . . . . . . . . . . . . . . . . . .      5,379            4           1,755           2
Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .        530           --             614           1
                                                                                ---------        -----       ---------        ----
     Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $137,632          100%       $ 99,766         100%
                                                                                ---------        -----       ---------        ----
                                                                                ---------        -----       ---------        ----


(1) Net of intercompany billings of $4,962,000 for the three months ended June
    30, 1996.
(2) Net of intercompany billings of $2,880,000 and $1,426,000 for the three
    months ended June 30, 1996 and 1995, respectively.




                                                                                              SIX MONTHS ENDED JUNE 30,
                                                                                              ---------------------------    
                                                                                            1996                        1995     
                                                                                            ----                        ----
                                                                                                 (dollars in thousands)
                                                                                                                    
Basic nursing care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $137,257           51%       $115,719          58%
Subacute . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .     84,410           32          62,751          32
                                                                                  --------          ----      ---------         ----
     Total in-patient operations . . . . . . . . . . . . . . . . . . . . . . .    221,667           83         178,470          90
Home healthcare operations . . . . . . . . . . . . . . . . . . . . . . . . . .     17,548            6          14,443           7
Contract rehabilitation therapy operations to
     non-affiliates (1). . . . . . . . . . . . . . . . . . . . . . . . . . . .     16,755            6              --          --
Pharmacy operations to non-affiliates (2). . . . . . . . . . . . . . . . . . .     10,105            4           3,287           2
Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .      1,520            1           1,114           1
                                                                                  --------          ----      ---------         ----
     Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $267,595          100%       $197,314         100%
                                                                                  --------          ----      ---------         ----
                                                                                  --------          ----      ---------         ----



(1) Net of intercompany billings of $7,890,000 for the six months ended June
    30, 1996.
(2) Net of intercompany billings of $5,352,000 and $2,678,000 for the six
    months ended June 30, 1996 and 1995, respectively.






    The following table sets forth certain operating data for the Company for
the periods presented:





                                  THREE MONTHS ENDED                      SIX MONTHS ENDED    
                                       JUNE 30,                                JUNE 30,  
                             --------------------------------     -------------------------------
                             1996                   1995             1996                 1995
                              ----                   ----             ----                 ----
                                                                           
Patient Days by Payor:
     Medicare                 79,733                 62,382         156,060              125,051
     Private/Other           191,264                171,686         373,923              342,926
     Managed Care             27,593                 23,221          59,643               47,657
     Medicaid                635,352                474,161       1,202,522              940,689
                            --------               --------      ----------           ----------
          Total              933,942                731,450       1,792,148            1,456,323
                            --------               --------      ----------           ----------
                            --------               --------      ----------           ----------

Home Health Visits            70,307                 66,017         145,284              128,031
Home Health Hours            109,171                101,336         215,049              168,741

Revenue Mix:
     Medicare                  29.9 %                 33.4 %          30.4 %               32.9 %
     Private/Other             23.9 %                 20.3 %          23.9 %               20.4 %
     Managed Care               4.9 %                  5.2 %           5.5 %                5.6 %
     Medicaid                  41.3 %                 41.1 %          40.2 %               41.1 %





        The following table presents the percentage of net operating revenue
represented by certain items reflected in the Company's Consolidated Statements
of Operations for the periods presented:






                                          THREE MONTHS ENDED               SIX MONTHS ENDED   
                                               JUNE 30,                         JUNE 30, 
                                      -------------------------     -------------------------------
                                         1996           1995           1996                 1995
                                          ----           ----           ----                 ----
                                               (Unaudited)                     (Unaudited)    
                                                                               
NET OPERATING REVENUE                      100.0 %      100.0 %         100.0 %              100.0 %
                                        ---------     --------        --------             --------

COSTS AND EXPENSES:
Operating expenses                          81.8         81.1            81.7                 81.0 
Corporate general and administrative         4.1          4.5             4.4                  4.9 
Rent expense                                 4.5          4.2             4.4                  4.2 
Depreciation and amortization                2.8          2.3             2.7                  2.3 
Interest expense                             3.0          1.9             3.1                  2.0 
Class action lawsuit settlement              0.0          3.1             0.0                  1.6 
                                        ---------     --------        --------             --------

     Total costs and expenses               96.2         97.1            96.3                 96.0 
                                        ---------     --------        --------             --------

INCOME BEFORE PROVISION FOR
INCOME TAXES                                 3.8 %        2.9 %           3.7 %                4.0 %
                                        ---------     --------        --------             --------
                                        ---------     --------        --------             --------






QUARTER COMPARISON 1996 TO 1995

NET OPERATING REVENUE

    The Company's net operating revenue for the three months ended June 30,
1996 ("Second Quarter 1996") was $137.6 million compared to $99.8 million for
the three months ended June 30, 1995 ("Second Quarter 1995"), an increase of
$37.8 million or 38.0%. 

    Net operating revenue from in-patient operations increased $23.7 million,
or 26.4%, to $113.6 million from $89.9 million primarily due to the 1996
acquisition of 18 in-patient facilities and, on a same store basis, a shift in
payor mix from Medicaid (42.8% to 41.2%) and private (14.7% to 12.9%) to
Medicare (30.3% to 31.4%) and managed care (5.9% to 6.9%), partially offset by a
slight decrease in total patient days. The 18 in-patient facilities acquired by
the Company in February 1996 contributed $20.9 million of net operating revenue
during Second Quarter 1996.  On a same store basis, the average increase in
reimbursement rates per patient day was 5.7% from Second Quarter 1995 and was
primarily due to providing services to higher acuity patients.  The Company
experienced a 0.4% net decrease in total patient days in Second Quarter 1996
from Second Quarter 1995 on a same store basis, consisting of a decrease of
3,402 and 7,960 from Medicaid and private and other sources, respectively, and
an increase of 3,830 and 4,447 from Medicare and managed care, respectively. 

     Net operating revenue from home healthcare operations grew $1.3 million to
$8.9 million, or 17.6% in Second Quarter 1996 over Second Quarter 1995,
primarily reflecting an increase in patient visits to 70,307 in Second Quarter
1996 from 66,017 in Second Quarter 1995 and an increase in treatment hours to
109,171 in Second Quarter 1996 from 101,336 in Second Quarter 1995.  Net
operating revenue from pharmacy operations to non-affiliates increased $3.6
million or 206.5% in Second Quarter 1996 over Second Quarter 1995, primarily due
to the acquisition of Assist-A-Care in January 1996 and Executive Pharmacy in
February 1996 (collectively, the "Pharmacy Acquisitions").  Net operating 
revenue from the Pharmacy Acquisitions for Second Quarter 1996 was $2.9 
million. Net operating revenue from contract rehabilitation therapy 
operations to non-affiliates was $9.3 million in Second Quarter 1996 and was 
a result of the purchase of SCRS in July 1995.  The Company had no net 
operating revenue from contract rehabilitation therapy operations in the 
Second Quarter 1995.

COSTS AND EXPENSES

    Total costs and expenses for Second Quarter 1996 increased $35.5 million,
or 37%, to $132.4 million (96.2% of net operating revenue) from $96.9 million
(97.1% of net operating revenue) for Second Quarter 1995. 

    Operating expenses as a percentage of net operating revenue increased to
81.8% for Second Quarter 1996, from 81.1% for Second Quarter 1995.  The increase
resulted from the incurrence of increased labor costs in the in-patient
operations while reimbursement rates per patient day for room and board charges
remained relatively flat for the Medi-Cal and Medicare systems.

    Corporate general and administrative expense is the corporate overhead and
regional costs related to the supervision of operations.  This expense decreased
as a percentage of net operating revenue to 4.1% for Second Quarter 1996 from
4.5% in Second Quarter 1995.  The decrease as a percentage of revenues is
attributed to achieving economies of scale through acquisition and same store
growth.

    Rent expense as a percentage of net operating revenue increased to 4.5% in
Second Quarter 1996 from 4.2% in Second Quarter 1995 primarily due to the 1996
Acquisitions.

    Depreciation and amortization expense as a percentage of net operating
revenue increased to 2.8% in Second Quarter 1996 from 2.3% in Second Quarter
1995 primarily due to goodwill amortization related to the purchase of SCRS in
July 1995 and the 1996 Acquisitions.




    Interest expense as a percentage of net operating revenue increased to 3.0%
in Second Quarter 1996 from 1.9% in Second Quarter 1995 primarily due to the
Company issuing the 9-7/8% Senior Subordinated Notes (the "Senior Subordinated
Notes") in October 1995 partially offset by the repayment of the 8.1% Senior
Secured Notes in that month.

    Pursuant to the settlement of a class action lawsuit, the Company recorded
a charge of $3.1 million in Second Quarter 1995.  The amount represents the
Company's portion of the settlement, together with related legal fees and other
costs.

SIX MONTHS COMPARISON 1996 TO 1995

NET OPERATING REVENUE

    The Company's net operating revenue for the six months ended June 30, 1996
("Six Months 1996") was $267.6 million compared to $197.3 million for the six
months ended June 30, 1995 ("Six Months 1995"), an increase of $70.3 million or
35.6%. 

    Net operating revenue from in-patient operations increased $43.2 million,
or 24.2%, to $221.7 million from $178.5 million due to the 1996 acquisition of
18 in-patient facilities and, on a same store basis, a shift in payor mix from
Medicaid (42.8% to 40.4%) and private (14.9% to 13.0%) to Medicare (29.6% to
31.6%) and managed care (6.2% to 7.5%).  The 18 in-patient facilities acquired
by the Company in February 1996 contributed $33.5 million of net operating
revenue during Six Months 1996.  On a same store basis, the average increase in
reimbursement rates per patient day was 7.2% and was primarily due to providing
services to higher acuity patients.

     Net operating revenue from home healthcare operations grew $3.1 million to
$17.5 million, or 21.5%, in Six Months 1996 over Six Months 1995, primarily
reflecting an increase in patient visits to 145,284 in Six Months 1996 from
128,031 in Six Months 1995 and an increase in treatment hours to 215,049 in Six
Months 1996 from 168,741 in Six Months 1995.  Net operating revenue from
pharmacy operations to non-affiliates increased $6.8 million or 207.4% in Six
Months 1996 over Six Months 1995, primarily due to the acquisition of
Assist-A-Care in January 1996 and Executive Pharmacy in February 1996
(collectively, the "Pharmacy Acquisitions").  Net operating revenue from the
Pharmacy Acquisitions for Six Months 1996 was $5.6 million.  Net operating
revenue from contract rehabilitation therapy operations to non-affiliates was
$16.8 million in Six Months 1996 and was a result of the purchase of SCRS in
July 1995.  The Company had no net operating revenue from contract
rehabilitation therapy operations in Six Months 1995.

COSTS AND EXPENSES

    Total costs and expenses for Six Months 1996 increased $68.1 million, or
36%, to $257.6 million (96.3% of net operating revenue) from $189.5 million
(96.0% of net operating revenue) for Six Months 1995. 

    Operating expenses as a percentage of net operating revenue increased to
81.7% for Six Months 1996, from 81.0% for Six Months 1995.  The increase
resulted from the incurrence of increased labor costs in the in-patient
operations while reimbursement rates per patient day for room and board charges
remained relatively flat for the Medi-Cal and Medicare systems.  In addition,
the home health agency participating in the Medicare Prospective Pay System
pilot project beginning in 1996 did not adequately reduce costs at the outset of
this program.

    Corporate general and administrative expense is the corporate overhead and
regional costs related to the supervision of operations.  This expense decreased
as a percentage of net operating revenue to 4.4% for Six Months 1996 from 4.9%
in Six Months 1995.  The decrease as a percentage of revenues is attributed to
achieving economies of scale through acquisition and same store growth.

    Rent expense as a percentage of net operating revenue increased to 4.4% in
Six Months 1996 from 4.2% in Six Months 1995 primarily due to the 1996
Acquisitions.




    Depreciation and amortization expense as a percentage of net operating
revenue increased to 2.7% in Six Months 1996 from 2.3% in Six Months 1995
primarily due to goodwill amortization related to the purchase of SCRS in July
1995 and the 1996 Acquisitions.

    Interest expense as a percentage of net operating revenue increased to 3.1%
in Six Months 1996 from 2.0% in Six Months 1995 primarily due to the Company
issuing the Senior Subordinated Notes in October 1995 partially offset by the
repayment of the Senior Secured Notes in that month.

    Pursuant to the settlement of a class action lawsuit, the Company recorded
a charge of $3.1 million in Six Months 1995.  The amount represents the
Company's portion of the settlement, together with related legal fees and other
costs.
    
LIQUIDITY AND CAPITAL RESOURCES

    Working capital at June 30, 1996 decreased $58.3 million to $61.0 million
(including cash and cash equivalents of $66.9 million) from $119.3 million
(including cash and cash equivalents of $104.2 million) at December 31, 1995. 
The decrease was primarily attributable to funding the purchase of the 1996
Acquisitions.  During the Six Months 1996, the Company's receivables increased
approximately $24 million primarily related to the 1996 Acquisitions. A portion
of the increase in receivables is due to delays in securing state and federal
provider numbers for certain of the 18 healthcare facilities acquired in the
1996 Acquisitions.  Management anticipates the collections related to the delay
will occur in the third and fourth quarter 1996.  In addition, the Company
established a revocable workers' compensation claims payment trust to pre-fund
its workers' compensation obligations which was funded in March 1996 with
approximately $10.6 million from available cash. (See Note 4 to the Consolidated
Financial Statements).

    The Company's major requirements for liquidity relate to funding working
capital, capital improvements and debt service obligations.  The Company must
also provide funding to cover potential delays, temporary cessations or
interruptions in payments by third-party payors due to political or budgetary
constraints.  Management believes that these liquidity needs can be met from
available cash, internally generated funds and existing borrowing capacity under
a revolving credit loan agreement ("Credit Agreement") with NationsBank of
Texas, N.A. as agent for a group of banks (discussed below).

    The Company's healthcare facilities require capital improvements for
renovations and improvements in physical appearance.  Future capital
improvements may be required as a result of routine regulatory inspections. In
addition, the Company is and will continue to invest in improving its
information systems. The Company's capital expenditures for the six months ended
June 30, 1996 and 1995 were approximately $5.6 million and $7.8 million,
respectively.  These capital expenditures have been financed through a
combination of internally generated funds and debt.  The Company expects to
spend approximately an aggregate of $13.0 million for capital expenditures
during 1996 to be financed through leases, borrowings under the Credit Agreement
and funds generated from operations.

    The Company has financed its acquisitions from a combination of borrowings
and funds generated by operations.  The Company expects to finance future
acquisitions from a combination of existing cash, the Credit Agreement, and
alternative sources such as real estate investment trusts.  Depending on the
numbers, size and timing of any such transactions, the Company may in the future
require additional financing in order to continue to make acquisitions.

    Periodically, the Company has funded temporary delays in reimbursement from
third-party payors.  For example, in July 1995, the State of California, due to
budgetary constraints, delayed payment of significant amounts owed to healthcare
providers under the Medi-Cal program.  In 1992, the State of California
reimbursed providers with registered warrants, which some banks temporarily
refused to redeem at face value.  The Company has been able to mitigate the
effects of such payment delays by monitoring the related activities of the
California legislature, expediting billings through its direct access electronic
billing arrangement, and obtaining the agreement of creditors to extend the due
date for payables.  The Company has not recently experienced any 




material adverse effects on its liquidity as a result of such delays.  There can
be no assurance, however, that the Company will be able to mitigate the effects
of any future funding delays by the State of California or other third-party
payors.

    In April and May 1996, the Company purchased 555,000 shares of Company
common stock at an average price of $9.16 per share.  The transaction, accounted
for using the cost method, reduced stockholders' equity by $5.1 million.

    On June 28, 1996 the Company issued 12 1/4% Subordinated Notes (the
"Subordinated Notes") in an aggregate amount of $50 million.  Interest on the
Notes will be payable semi-annually on January 15 and July 15 of each year,
commencing January 15, 1997.  The Notes will mature on July 15, 2003, unless
previously redeemed.  Net proceeds received by the Company totaled approximately
$48.4 million and funded the redemption of the Company's outstanding 6 1/2%
Convertible Subordinated Debentures due 2003 on July 29, 1996.

    On December 28, 1995 the Company entered into the Credit Agreement, which
provides up to $50,000,000 in a revolving line of credit and letters of credit. 
As of July 31, 1996, no borrowings have been drawn on the Credit Agreement and
approximately $9,000,000 of standby letters of credit have been issued in
connection with the Company's self-insured workers' compensation programs.

SEASONALITY

    The Company's income from operations before fixed charges generally
fluctuates from quarter to quarter.  The fluctuation is related to several
factors: the timing of Medicaid rate increases, seasonal census cycles, and the
number of calendar days in a given quarter.  As a result, the Company's income
from operations before fixed charges tends to be higher in its third and fourth
quarters when compared to the first and second quarters.

IMPACT OF INFLATION

    The healthcare industry is labor intensive.  Wages and other labor costs
are especially sensitive to inflation.  Increases in wages and other labor costs
as a result of inflation, or increases in federal or state minimum wages without
a corresponding increase in Medicare and Medicaid reimbursement rates, could
adversely impact the Company.

REIMBURSEMENT

    The majority of the Company's net operating revenue is derived from
services provided under the Medicare and Medicaid programs.  Numerous proposals
relating to healthcare reform have been or may be introduced in the United
States Congress, state legislatures or by governmental agencies who regulate the
Medicare and Medicaid programs.  It is uncertain what reform will ultimately be
enacted by the federal government, any state government or governmental agencies
and therefore, the Company cannot predict at this time the impact on the Company
of any proposed reforms.

    As discussed above, the Company provides contract rehabilitation and
pharmacy services to both Regency operated and non-affiliated facilities.  Under
current Medicare regulations, reimbursement for these services provided to
Medicare eligible patients in Regency facilities is based upon the related
entity's cost to provide the services unless a significant portion of the
related entity's revenues is derived from non-affiliated facilities.  If a 
significant portion of the related entity's revenues is derived from 
non-affiliated facilities, Medicare will reimburse the facility's cost, which 
includes a profit paid to the related entity.  During 1995 and prior years, 
the Company was reimbursed by Medicare based on its pharmacy operation costs 
on billings to Regency facilities, as it did not meet the significant portion 
criteria.  After the acquisition of Assist-A-Care Pharmacy and Executive 
Pharmacy in 1996, the Company believes it meets the "significant portion" 
criteria and began recording a profit on billings for pharmacy services 
provided to Medicare eligible patients in Regency facilities.  The Company 
believes it meets the "significant portion" criteria for its contract 
rehabilitation therapy operations provided by SCRS, and therefore has 
recorded a profit on billings to Regency facilities since the acquisition of 
SCRS.  




Medicare regulations do not define a "significant portion," therefore, the
Company's and Medicare's interpretations could differ, which could result in
retroactive adjustments related to the profit on billings to Regency facilities
for pharmacy and contract rehabilitation services. 

    In the recently enacted federal budget deficit reduction bill, various
reimbursement rules and regulations were adopted by the federal government that
pertain to the Company.  The recently effective changes to regulations
promulgated under OBRA, some of which expand the remedies available to enforce
regulations mandating minimum healthcare standards, may have an adverse effect
on the Company's operations.  The Company is unable to predict the particular
effect on the Company until the manner in which these regulations is implemented
becomes known.






                              PART II. OTHER INFORMATION
                                           

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.

(a)     Exhibits

        4.11     Indenture, dated as of June 28, 1996, between Regency Health
Services, Inc. as Issuer, the Guarantors named therein and U.S. Trust Company of
California, N.A., as Trustee.

        4.12     Form 12-1/4% Subordinated Note due 2003 of Regency Health
Services, Inc. (included in Exhibit 4.11).

        4.13     Registration Rights Agreement, dated as of June 28, 1996, by
and among Regency Health Services, Inc., as Issuer, the Guarantors named therein
and Bear, Stearns & Co., Inc. and NationsBanc Capital Markets, Inc., as Initial
Purchasers.

(b)     Reports on Form 8-k

        Current Report on Form 8-K/A, dated April 12, 1996, reporting an event
dated February 1, 1996 under Items 2 and 7 of Form 8-K, and filing the following
audited financial statements of Liberty Healthcare Limited Partnership:  (i)
balance sheets as of September 30, 1994 and 1995, (ii) statements of partners'
capital for the years ended September 30, 1994 and 1995, (iii) statements of
income for the years ended September 30, 1994 and 1995, and (iv) statements of
cash flows for the years ended September 30, 1994 and 1995.  




        Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.



REGENCY HEALTH SERVICES, INC.



By:     /s/ BRUCE D BROUSSARD
        _____________________________________________________
        Bruce D. Broussard
        Executive Vice President and Chief Financial Officer



Date:   August 14, 1996